Impairment of endothelial function after a high-fat meal in patients with coronary artery disease

S P Zhao1, L Liu, M Gao

  • 1Department of Cardiology, Second Affiliated Hospital of Central South University, Changsha, China.

Coronary Artery Disease
|November 21, 2001
PubMed

Insights

A high-fat meal impairs endothelial function, particularly in coronary artery disease (CAD) patients. Postprandial lipid changes, especially triglycerides, are linked to this endothelial dysfunction, suggesting a role in atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Lipid Metabolism

Background:

  • Endothelial dysfunction is a key factor in coronary artery disease (CAD) pathogenesis.
  • Postprandial lipid excursions following a high-fat meal can impact vascular health.
  • Normocholesterolemic individuals may still experience adverse effects from postprandial dyslipidemia.

Purpose of the Study:

  • To investigate the impact of postprandial lipid changes on endothelial function in CAD patients.
  • To compare the effects of a high-fat meal on endothelial function in CAD patients versus healthy controls.
  • To explore the relationship between triglyceride levels and endothelial function after a meal.

Main Methods:

  • Study included 50 CAD patients and 25 normocholesterolemic controls.
  • High-resolution ultrasound assessed brachial artery flow-mediated vasodilatation (FMD).
  • FMD was measured before and after a standardized high-fat meal (800 calories, 50g fat).

Main Results:

  • Postprandial serum triglyceride levels significantly increased 2-7 hours after the meal.
  • Mean FMD was significantly impaired in both CAD patients and controls post-meal.
  • The impairment in FMD was more pronounced in CAD patients compared to controls (44.4% vs 25.9%).
  • Increased 2-hour triglyceride levels correlated with reduced FMD.

Conclusions:

  • A single high-fat meal severely impairs endothelium-dependent vasodilatation in both CAD patients and controls.
  • Disordered postprandial metabolism of triglyceride-rich lipoproteins may contribute to endothelial dysfunction.
  • This dysfunction could play an atherogenic role in the progression of cardiovascular disease.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...